Citation Impact
Citing Papers
Global increase and geographic convergence in antibiotic consumption between 2000 and 2015
2018 Standout
Nucleic acid detection with CRISPR-Cas13a/C2c2
2017 StandoutScience
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
2016 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
2017 Standout
Infective Endocarditis
2005 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Vitamin D deficiency is associated with community-acquired clostridium difficile infection: a case–control study
2014
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
2015 Standout
Effectiveness of drug use evaluation and antibiotic authorization on patients' clinical outcomes, antibiotic consumption, and antibiotic expenditures
2009
Two Time-Series Analyses of the Impact of Antibiotic Consumption and Alcohol-Based Hand Disinfection on the Incidences of Nosocomial Methicillin-Resistant Staphylococcus aureus Infection and Clostridium difficile Infection
2009
Toxoplasmosis
2004 Standout
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
2020 Standout
An array of target-specific screening strains for antibacterial discovery
2002
Telavancin: A Novel Lipoglycopeptide
2009
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
2007 Standout
Fluoroquinolone Use and Methicillin-Resistant Staphylococcus aureus Isolation Rates in Hospitalized Patients: A Quasi Experimental Study
2006
The Impact of ICD-9-CM Code Rank Order on the Estimated Prevalence of Clostridium difficile Infections
2011
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Clinical practice patterns of managing low-risk adult febrile neutropenia during cancer chemotherapy in the USA
2007
Antibiotics in the aquatic environment – A review – Part I
2009 Standout
Comparison of Outpatient Systemic Antibacterial Use in 2004 in the United States and 27 European Countries
2007
Temporal effects of antibiotic use and hand rub consumption on the incidence of MRSA and Clostridium difficile
2008
Clostridium difficileInfections among Hospitalized Children, United States, 1997–2006
2010
Effect of Solar Particle Event Radiation and Hindlimb Suspension on Gastrointestinal Tract Bacterial Translocation and Immune Activation
2012 StandoutNobel
What Antimicrobial Resistance Has Taught Us About Horizontal Gene Transfer
2009
Generally Overlooked Fundamentals of Bacterial Genetics and Ecology
2002
Impact of a Prospective-Audit-With-Feedback Antimicrobial Stewardship Program at a Children's Hospital
2012
Hand Hygiene, and Not Ertapenem Use, Contributed to Reduction of Carbapenem-Resistant Pseudomonas aeruginosa Rates
2011
Drugs for bad bugs: confronting the challenges of antibacterial discovery
2006 Standout
Waves of resistance: Staphylococcus aureus in the antibiotic era
2009 Standout
Role of the Microbiota in Immunity and Inflammation
2014 Standout
Antibacterial resistance worldwide: causes, challenges and responses
2004 Standout
Antibiotic resistance and its cost: is it possible to reverse resistance?
2010 Standout
Hospital-wide modification of fluoroquinolone policy and meticillin-resistant Staphylococcus aureus rates: a 10-year interrupted time-series analysis
2011
Resistance to Antibiotics: Are We in the Post-Antibiotic Era?
2005 Standout
Broad-Spectrum Antibiotic or G-CSF as Potential Countermeasures for Impaired Control of Bacterial Infection Associated with an SPE Exposure during Spaceflight
2015 StandoutNobel
Interventions to improve antibiotic prescribing practices for hospital inpatients
2013 Standout
Understanding the mechanisms and drivers of antimicrobial resistance
2015 Standout
Carbapenem-Resistant Enterobacteriaceae: Epidemiology and Prevention
2011 Standout
Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine
2009
Benchmarking antimicrobial drug use in hospitals
2012
Fluoroquinolones: Action and Resistance
2003
Audit and Feedback to Reduce Broad-Spectrum Antibiotic Use among Intensive Care Unit Patients A Controlled Interrupted Time Series Analysis
2012
Fluoroquinolone-Resistant Pseudomonas aeruginosa: Assessment of Risk Factors and Clinical Impact
2006
De-escalation versus continuation of empirical antimicrobial therapy in community-acquired pneumonia
2016
Antimicrobial resistance: a global multifaceted phenomenon
2015 Standout
Impact of the pharmacist on a multidisciplinary team in an antimicrobial stewardship program: a quasi-experimental study
2012
Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat
2006
Community-Acquired Pneumonia Requiring Admission to an Intensive Care Unit
2007
The Morbidity, Mortality, and Costs Associated with Clostridium difficile Infection
2015
Occurrence and fate of quinolone and fluoroquinolone antibiotics in a municipal sewage treatment plant
2011
Occurrence of pharmaceutical compounds in urban wastewater: Removal, mass load and environmental risk after a secondary treatment—A review
2012 Standout
Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
2010 Standout
Cumulative Antibiotic Exposures Over Time and the Risk of Clostridium difficile Infection
2011
A computational approach for predicting off-target toxicity of antiviral ribonucleoside analogues to mitochondrial RNA polymerase
2018 StandoutNobel
Targeting DNA topoisomerase II in cancer chemotherapy
2009 Standout
Pseudomonas aeruginosa Disrupts Caenorhabditis elegans Iron Homeostasis, Causing a Hypoxic Response and Death
2013 StandoutNobel
Toxoplasmic Encephalitis in AIDS
1992 Standout
Lessons Learned from ImplementingClostridium difficile–Focused Antibiotic Stewardship Interventions
2014
A plastid organelle as a drug target in apicomplexan parasites
1997 StandoutNature
Trimethoprim-Sulfamethoxazole Compared with Vancomycin for the Treatment of Staphylococcus aureus Infection
1992
Predictors of Clostridium difficile infection and predictive impact of probiotic use in a diverse hospital-wide cohort
2018
Cryo-EM structure of a type IV secretion system
2022 StandoutNatureNobel
Evaluation of Hospital Room Assignment and Acquisition of Clostridium difficile Infection
2011
Reduction of fluoroquinolone use is associated with a decrease in methicillin-resistant Staphylococcus aureus and fluoroquinolone-resistant Pseudomonas aeruginosa isolation rates: a 10 year study
2012
Antifouling Coatings: Recent Developments in the Design of Surfaces That Prevent Fouling by Proteins, Bacteria, and Marine Organisms
2010 Standout
Current Recommendations and Future Prospects in the Treatment of Toxoplasmosis
1989
Vancomycin Revisited – 60 Years Later
2014
The pros, cons, and many unknowns of probiotics
2019 Standout
Antibiotic efficacy and microbial virulence during space flight
2006
Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
2019 Standout
Strategies to Prevent Clostridium difficile Infections in Acute Care Hospitals: 2014 Update
2014
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Differential Effects of Levofloxacin and Ciprofloxacin on the Risk for Isolation of Quinolone-Resistant Pseudomonas aeruginosa
2006
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
2011 Standout
Bacterial Resistance to β-Lactam Antibiotics: Compelling Opportunism, Compelling Opportunity
2005 Standout
Improving Quinolone Use in Hospitals by Using a Bundle of Interventions in an Interrupted Time Series Analysis
2010
Comprehensive Evaluation of Antibiotics Emission and Fate in the River Basins of China: Source Analysis, Multimedia Modeling, and Linkage to Bacterial Resistance
2015 Standout
Fluorine in Pharmaceuticals: Looking Beyond Intuition
2007 StandoutScience
Variability in Antibiotic Use Across Nursing Homes and the Risk of Antibiotic-Related Adverse Outcomes for Individual Residents
2015
Reengineering Antibiotics to Combat Bacterial Resistance: Click Chemistry [1,2,3]‐Triazole Vancomycin Dimers with Potent Activity against MRSA and VRE
2016 StandoutNobel
Guidance on the Selection of Appropriate Indicators for Quantification of Antimicrobial Usage in Humans and Animals
2016
Diverse and abundant antibiotic resistance genes in Chinese swine farms
2013 Standout
Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections
2010 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Pharmaceuticals of Emerging Concern in Aquatic Systems: Chemistry, Occurrence, Effects, and Removal Methods
2019 Standout
Burn Wound Infections
2006 Standout
Multistate Point-Prevalence Survey of Health Care–Associated Infections
2014 Standout
Best Practice Policy Statement on Urologic Surgery Antimicrobial Prophylaxis
2008
Association between Antimicrobial Consumption and Resistance in Escherichia coli
2008
Trovafloxacin is active against Toxoplasma gondii
1996
Decreasing Clostridium difficile Infections by an Antimicrobial Stewardship Program That Reduces Moxifloxacin Use
2014
Antimicrobial Stewardship Programs in Health Care Systems
2005
Comparison of conventional dosing versus continuous-infusion vancomycin therapy for patients with suspected or documented gram-positive infections
1996
Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship
2006 Standout
Works of Ronald E. Polk being referenced
Metabolic Disposition and Pharmacokinetics of [14C]‐Amprenavir, a Human Immunodeficiency Virus Type 1 (HIV‐1) Protease Inhibitor, Administered As a Single Oral Dose to Healthy Male Subjects
2001
Trends in Antibacterial Use in US Academic Health Centers
2008
Measurement of Adult Antibacterial Drug Use in 130 US Hospitals: Comparison of Defined Daily Dose and Days of Therapy
2007
Variability in Rates of Use of Antibacterials Among 130 US Hospitals and Risk-Adjustment Models for Interhospital Comparison
2008
Hospital and Community Fluoroquinolone Use and Resistance in Staphylococcus aureus and Escherichia coli in 17 US Hospitals
2005
Use of International Classification of Diseases, Ninth Revision Clinical Modification Codes and Medication Use Data to Identify Nosocomial Clostridium difficile Infection
2009
Trends in Antibacterial Use in Hospitalized Pediatric Patients in United States Academic Health Centers
2009
Vancomycin and the Red-Man Syndrome: Pharmacodynamics of Histamine Release
1988
Economic Impact of Clostridium difficile Infection in a Multihospital Cohort of Academic Health Centers
2011
Sulfadiazine-induced crystalluria in a patient with the acquired immunodeficiency syndrome: a reminder
1988
Predicting Hospital Rates of Fluoroquinolone-Resistant Pseudomonas aeruginosa from Fluoroquinolone Use in US Hospitals and Their Surrounding Communities
2004
Antimicrobial use and bacterial resistance
2000
Gentamicin and Tobramycin Penetration Into Burn Eschar
1983
Relationship of Carbapenem Restriction in 22 University Teaching Hospitals to Carbapenem Use and Carbapenem-Resistant Pseudomonas aeruginosa
2009
Pharmacokinetics and serum bactericidal titers of ciprofloxacin and ofloxacin following multiple oral doses in healthy volunteers
1993
Statin use and the risk of Clostridium difficile in academic medical centres
2012
Characterization of Continued Antibacterial Therapy After Diagnosis of Hospital‐Onset C lostridium difficile Infection: Implications for Antimicrobial Stewardship
2012
Pharmacokinetics of [ 14 C]Abacavir, a Human Immunodeficiency Virus Type 1 (HIV-1) Reverse Transcriptase Inhibitor, Administered in a Single Oral Dose to HIV-1-Infected Adults: a Mass Balance Study
1999